C-reactive protein level indicates AMD risk

Article

People with high blood levels of C-reactive protein may be at higher risk of developing age-related macular degeneration.

People with high blood levels of C-reactive protein may be at higher risk of developing age-related macular degeneration (AMD), according to a report published in October issue of Archives of Ophthalmology.

Sharmila S. Boekhoorn and colleagues from the Erasmus Medical Centre, Rotterdam, the Netherlands collected blood samples and took photographs of the eyes of more than 4,900 people at risk from AMD and followed the group for an average of 7.7 years. During this period, 658 subjects were diagnosed with AMD; 561 with initial stage AMD and 97 with advanced AMD.

It was found that as a person's C-reactive protein level increased the person became more and more likely to develop AMD.

The researchers suggest that lowering C-reactive protein levels may help decrease the risk of developing AMD.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.